Long-term management of vulval lichen sclerosus in adult women

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 50, Issue 2, 2010, Pages 148-152

  Bradford, J ^a   Fischer, G ^b,c  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Lichen sclerosus; Skin diseases; Vulva; Vulvar cancer

Indexed keywords

ANTIFUNGAL AGENT; BETAMETHASONE DIPROPIONATE; CORTICOSTEROID; ESTROGEN; FLUCONAZOLE; HYDROCORTISONE; ITRACONAZOLE; METHYLPREDNISOLONE ACEPONATE;

ADULT; AGED; ARTICLE; CANDIDIASIS; CLINICAL FEATURE; DATA ANALYSIS; DERMATITIS; DISEASE COURSE; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; DRUG SAFETY; FEMALE; FISHER EXACT TEST; FOLLOW UP; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PATIENT COMPLIANCE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SCAR FORMATION; SELF REPORT; SKIN ATROPHY; SQUAMOUS CELL CARCINOMA; SYMPTOM; VAGINA ATROPHY; WOMEN'S HEALTH;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDIASIS; CARCINOMA, SQUAMOUS CELL; CICATRIX; DERMATITIS; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VULVAR LICHEN SCLEROSUS; VULVAR NEOPLASMS; YOUNG ADULT;

EID: 77950906585     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2010.01142.x     Document Type: Article

References (27)

1. Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, Dubertret L. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol 2004 140 (6 709 712. (Pubitemid 38747287)
2. Bornstein J, Heifetz S, Kellner Y, Stola Z, Abramovici H. Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus. Am J Obstet Gynecol 1998 178 : 80 84. (Pubitemid 28302799)
3. Cooper SM, Gao X-H, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 2004 140 (6 702 706. (Pubitemid 38747286)
4. Dalziel KL, Millard PR, Wojnarowska F. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.0%) cream. Br J Dermatol 1991 124 : 461 464.
5. Dalziel KL, Wojnarowska F. Long-term control of vulval licen sclerosus after tretment with a potent topical steroid cream. J Reprod Med 1993 38 : 25 27. (Pubitemid 23049732)
6. Garzon MC, Paller AS. Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus. Arch Dermatol 1999 135 (5 525 528.
7. Lorenz B, Kaufman RH, Kutzner S. Lichen sclerosus therapy with clobetasl propionate. J Reprod Med 1998 43 : 790 794. (Pubitemid 28430693)
8. Sinha R, Sorinola O, Luesley D. Lichen sclerosus of the vulva long-term steroid maintenance therapy. J Reprod Med 1999 44 : 621 624. (Pubitemid 29350460)
9. Smith YR, Quint EH. Clobetasol propionate in the treatment of premenarchal vulvar lichen sclerosus. Obstet Gynecol 2001 98 : 588 591.
10. Carli P, Cattaneo A, De Magnis A, Biggeri A, Taddei G, Gianotti B. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev 1995 4 : 491 495.
11. Scurry JP, Vanin K. Vulvar squamous cell carcinoma and lichen sclerosus. Australas J Dermatol 1997 38 (Suppl 1 S20 S25.
12. Neill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol 2002 147 (2 640 649.
13. Wallace H. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971 57 : 9 30.
14. Neill SM, Ridley CM. Management of anogenital lichen sclerosus. Clin Exp Dermatol 2001 26 : 637 643.
15. Jones RW, Sadler L, Grant S, Whineray J, Exter M, Rowan D. Clinically identifying women with vulval lichen sclerosus at inreased risk of squamous cell carcinoma: a case-control study. J Reprod Med 2004 49 (10 808 811. (Pubitemid 39431177)
16. Jones RW, Scurry J, Neill S, MacLean AB. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics. Am J Obstet Gynecol 2008 198 (5 496. e1-3. (Pubitemid 351622064)
17. Bracco GL, Carli P, Sonni L, Maestrini G, De Marco A, Taddei GL, Cattaneo A. Clinical and histologic effects of topical treatments of vulval lichen sclerosus: a critical evaluation. J Reprod Med 1993 38 : 37 40. (Pubitemid 23049735)
18. Fischer G, Bradford J. Topical immunosuppressants, genital lichen sclerosus and the risk of squamous cell carcinoma. J Reprod Med 2007 52 (4 329031. (Pubitemid 46668882)
19. Lewis FM, Neill SM. Safety of calcineurin inhibitors in the management of lichen sclerosus. Br J Dermatol 2007 156 (6 1389 1390. (Pubitemid 47029844)
20. Cattaneo A, De Magnis A, Botti E, Sonni L, Carli P, Taddei GL. Topical mometasone fuoate for vulvar lichen sclerosus. J Reprod Med 2003 48 : 444 448. (Pubitemid 36741574)
21. Smith YR, Haefner HK. Vulvar lichen sclerosus: pathophysiology and treatment. Am J Clin Dermatol 2004 5 (2 105 125. (Pubitemid 38626393)
22. Funaro D. Lichen sclerosus: a review and practical approach. Dermatol Ther 2004 17 (1 28 37.
23. Val I, Almeida G. An overview of lichen sclerosus. Clin Obstet Gynecol 2005 48 (4 808 817. (Pubitemid 43019256)
24. The American College of Obstetricians and Gynecologists. Practice bulletin no. 93. Obstet Gynecol 2008 111 (5 1243 1253.
25. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999 353 : 1777 1783.
26. Yesudian PD, Sugunendran H, Bates CM, O'Mahony C. Lichen sclerosus. Int J STD AIDS 2005 16 : 465 474. (Pubitemid 41003146)
27. Tasker GL, Wojnarowska F. Lichen sclerosus. Clin Exp Dermatol 2003 28 : 128 133. (Pubitemid 36459613)